{"organizations": [], "uuid": "8d9b5b759237df44dc449d8d7ad6ab02790c6a09", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-biomarin-q4-gaap-loss-per-share-03/brief-biomarin-q4-gaap-loss-per-share-0-30-idUSASB0C746", "country": "US", "domain_rank": 408, "title": "BRIEF-BioMarin Q4 GAAP Loss Per Share $0.30", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-22T23:15:00.000+02:00", "replies_count": 0, "uuid": "8d9b5b759237df44dc449d8d7ad6ab02790c6a09"}, "author": "", "url": "https://www.reuters.com/article/brief-biomarin-q4-gaap-loss-per-share-03/brief-biomarin-q4-gaap-loss-per-share-0-30-idUSASB0C746", "ord_in_thread": 0, "title": "BRIEF-BioMarin Q4 GAAP Loss Per Share $0.30", "locations": [], "entities": {"persons": [{"name": "reu", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "biomarin", "sentiment": "none"}, {"name": "biomarin pharmaceutical inc", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 17 PM / Updated 5 minutes ago BRIEF-BioMarin Q4 GAAP Loss Per Share $0.30 Reuters Staff Feb 22 (Reuters) - BioMarin Pharmaceutical Inc: * BIOMARIN ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS * Q4 GAAP LOSS PER SHARE $0.30 * QTRLY TOTAL REVENUES $358.3 MILLION VERSUS $300.1 MILLION * SEES 2018 TOTAL REVENUES $1,470 MILLION TO $1,530 MILLION * SEES 2018 GAAP NET LOSS OF $115 MILLION TO $165 MILLION * SEES 2018 NON-GAAP INCOME OF $100 MILLION TO $140 MILLION * Q4 REVENUE VIEW $351.6 MILLION -- THOMSON REUTERS I/B/E/S * FY2018 REVENUE VIEW $1.48 BILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-22T23:15:00.000+02:00", "crawled": "2018-02-22T23:31:10.010+02:00", "highlightTitle": ""}